Copertina

RETRACTION : miR ‐25‐3p Reverses Epithelial‐Mesenchymal Transition via Targeting Sema4C in Cisplatin‐Resistance Cervical Cancer Cells

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Cancer Science
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Engineered EVs‐Mediated miR‐222 Targeting PTEN/FN1 Axis Reverses Anthracycline Resistance in HER2‐Negative Breast Cancer
di: Sujin Yang, et al.
Pubblicazione: (2025)

Crucial Contribution of BACH1 to Bladder Cancer Progression via Upregulating Epithelial‐Mesenchymal Transition Pathway
di: Tomoya Hatayama, et al.
Pubblicazione: (2025)

RETRACTION: Role of the MUC1‐C Oncoprotein in the Acquisition of Cisplatin Resistance by Urothelial Carcinoma
Pubblicazione: (2025)

The LGALS9 / miR ‐491‐5p Axis Regulates CD8 + T Cell Function and Inhibits the Progression of Gastric Cancer
di: Wanzhong Huang, et al.
Pubblicazione: (2025)

Downregulation of Chromosome 19 miRNA Cluster and the Tumor‐Suppressive Role of miR ‐517a‐3p in Choriocarcinoma
di: Yuki Nishiko, et al.
Pubblicazione: (2025)

Epithelial–Mesenchymal Transition and Genetically Driven Early Tumor Seedings in Extraneural Metastasis of Glioblastoma
di: Seisaku Kanayama, et al.
Pubblicazione: (2025)

RETRACTION : Exosomal miR ‐106a‐5p Accelerates the Progression of Nasopharyngeal Carcinoma Through FBXW7 ‐Mediated TRIM24 Degradation
Pubblicazione: (2024)

Antiproliferative Effects of Cannabinoids and Cisplatin in Cervical Cancer Cells
di: S. P. Mathibela, et al.
Pubblicazione: (2026)

RETRACTION : Hsp27 Regulates EGF /β‐Catenin Mediated Epithelial to Mesenchymal Transition in Prostate Cancer
Pubblicazione: (2025)

Correction to “Increased Expression of miR ‐641 Contributes to Erlotinib Resistance in Non‐Small‐Cell Lung Cancer Cells by Targeting NF1 ”
Pubblicazione: (2025)

Circular RNA circWNK1 inhibits the progression of gastric cancer via regulating the miR‐21‐3p/SMAD7 axis
di: Ting Dai, et al.
Pubblicazione: (2024)

Correction to: HDAC5 , Negatively regulated by miR ‐ 148a‐ 3p, promotes colon cancer cell migration
Pubblicazione: (2024)

N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR ‐1236‐3p/ GPX2 Axis
di: Qian Li, et al.
Pubblicazione: (2025)

Epithelial‐Mesenchymal Plasticity in the D‐Meso‐Sonobe Mesothelioma Cell Line: A Putative Model of Epithelial–Mesenchymal Transition in Mesothelioma
di: Hiroshi Okubo, et al.
Pubblicazione: (2025)

FAM3C Regulates Glioma Cell Proliferation, Invasion, Apoptosis, and Epithelial Mesenchymal Transition via the Notch Pathway
di: Xiaochao Xia, et al.
Pubblicazione: (2024)

lncDILC Downregulation in Liver Cancer‐Associated Fibroblasts Drives Pro‐Invasive Conversion via a miR ‐6071‐ ZNF395 Axis
di: Yawen Li, et al.
Pubblicazione: (2025)

RETRACTION : The Role and Molecular Mechanism of Trop2 Induced Epithelial–Mesenchymal Transition Through Mediated β‐Catenin in Gastric Cancer
Pubblicazione: (2025)

Sortilin‐1, Targeted by miR‐146a, Regulates the Behavior of Non‐Small Cell Lung Cancer
di: Xi Lin, et al.
Pubblicazione: (2025)

RETRACTION: LncRNA NKILA Promotes Epithelial‐Mesenchymal Transition of Liver Cancer Cells by Targeting miR‐485‐5p
di: Journal of Oncology
Pubblicazione: (2025)

LncRNA MIR600HG inhibits laryngeal cancer development by mediating the miR‐424‐5p/BTG2 axis
di: Xiaowen Zhu, et al.
Pubblicazione: (2024)

RESOLVED EXPRESSION OF CONCERN : Long Non‐coding RNA Urothelial Cancer‐associated 1 Promotes Bladder Cancer Cell Migration and Invasion by Way of the hsa‐ miR ‐145– ZEB1 /2– FSCN1 Pathway
Pubblicazione: (2025)

Hypoxia Inhibitor Improves Iodine Uptake Disorder in Thyroid Cancer Through the hsa_circ_0023990/miR‐448/DNMT1/NIS Axis
di: Ruiqin Gou, et al.
Pubblicazione: (2025)

PEGylated Chitosan Nanoparticles: Engineering Multifunctional Platforms for Targeted Cervical and Lung Cancer Treatment
di: Prashant Kesharwani, et al.
Pubblicazione: (2026)

Pulmonary Delivery of TCR Bispecific Proteins via Mesenchymal Stem Cells Facilitates Efficient Clearance of Lung Cancers
di: Teng Wei, et al.
Pubblicazione: (2025)

Correction to “ miR ‐203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver”
Pubblicazione: (2024)

Arteannuin B Inhibits NSCLC Cells via Regulating miR ‐194‐3p/ CLDN2 Axis
di: Ting‐Sha He, et al.
Pubblicazione: (2026)

FB23 ‐2 and Cisplatin Synergize to Inhibit Head and Neck Squamous Cell Carcinoma by Targeting the XPF / ERCC1 Complex
di: Yaoqi Jiang, et al.
Pubblicazione: (2026)

Zebrafish Xenograft Model for Predicting Cisplatin Efficacy in Muscle‐Invasive Bladder Cancer
di: Yusuke Sugino, et al.
Pubblicazione: (2025)

Exosomal miR‐199a‐3p Secreted From Cancer‐Associated Adipocytes Promotes Pancreatic Cancer Progression
di: Kazuyoshi Noda, et al.
Pubblicazione: (2024)

Integrated Network Analysis Decipher ZNF384 ‐Related miR ‐20b‐5p and miR ‐424‐5p in Colon Adenocarcinoma
di: Bo Zhang, et al.
Pubblicazione: (2025)

RETRACTION: Silencing Circular RNA VANGL1 Inhibits Progression of Bladder Cancer by Regulating miR‐1184/IGFBP2 Axis
Pubblicazione: (2025)

Targeting the mTOR Signaling Pathway Through miR‐100 and miR‐101 in De Novo Acute Myeloid Leukemia: Implications for Therapeutic Intervention
di: Maryam Kargar, et al.
Pubblicazione: (2025)

miR‐224‐5p Suppresses Non‐Small Cell Lung Cancer via IL6ST‐Mediated Regulation of the JAK2/STAT3 Pathway
di: Jiao Tian, et al.
Pubblicazione: (2025)

PRR11 Promotes Bladder Cancer Growth and Metastasis by Facilitating G1/S Progression and Epithelial‐Mesenchymal Transition
di: Lu Wang, et al.
Pubblicazione: (2025)

Correction to “ lncRNA XLOC013218 Promotes Cell Proliferation and TMZ Resistance by Targeting the PIK3R2 ‐Mediated PI3K / AKT Pathway in Glioma”
Pubblicazione: (2025)

Targeting Cancer With Bifunctional Peptides: Mechanism of Cell Entry and Inciting Cell Death
di: Maria F. Setiawan, et al.
Pubblicazione: (2025)

Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case Report
di: Maako Kawamura, et al.
Pubblicazione: (2025)

Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR‐378a‐3p/VEGFA/RGC‐32 Axis
di: Jinli He, et al.
Pubblicazione: (2024)

Mefloquine Suppresses Metastasis in Renal Cell Carcinoma Through Targeting SPC25
di: Yongbo Wang, et al.
Pubblicazione: (2025)

TGM2 Regulates Radiosensitivity via POGZ ‐Mediated Repair of DNA Double‐Strand Breaks in Cervical Cancer
di: Yunbo Chi, et al.
Pubblicazione: (2025)